Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cellular differentiation
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Importance of epigenetic control=== The first question that can be asked is the extent and complexity of the role of epigenetic processes in the determination of cell fate. A clear answer to this question can be seen in the 2011 paper by Lister R, ''et al.'' <ref name = "Lister">{{cite journal | vauthors = Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR | title = Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells | journal = Nature | volume = 471 | issue = 7336 | pages = 68β73 | date = March 2011 | pmid = 21289626 | pmc = 3100360 | doi = 10.1038/nature09798 | bibcode = 2011Natur.471...68L }}</ref> on aberrant epigenomic programming in [[human]] [[induced pluripotent stem cells]]. As induced pluripotent stem cells (iPSCs) are thought to mimic [[embryonic stem cells]] in their pluripotent properties, few epigenetic differences should exist between them. To test this prediction, the authors conducted whole-genome profiling of [[DNA methylation]] patterns in several human embryonic stem cell (ESC), iPSC, and progenitor cell lines. Female [[adipose]] cells, [[lung]] [[fibroblasts]], and foreskin fibroblasts were reprogrammed into induced pluripotent state with the [[OCT4]], [[SOX2]], [[KLF4]], and [[MYC]] genes. Patterns of DNA methylation in ESCs, iPSCs, somatic cells were compared. Lister R, ''et al.'' observed significant resemblance in methylation levels between embryonic and induced pluripotent cells. Around 80% of [[CpG site|CG dinucleotides]] in ESCs and iPSCs were methylated, the same was true of only 60% of CG dinucleotides in somatic cells. In addition, somatic cells possessed minimal levels of [[cytosine methylation]] in non-CG dinucleotides, while induced pluripotent cells possessed similar levels of methylation as embryonic stem cells, between 0.5 and 1.5%. Thus, consistent with their respective transcriptional activities,<ref name= "Lister"/> DNA methylation patterns, at least on the genomic level, are similar between ESCs and iPSCs. However, upon examining methylation patterns more closely, the authors discovered 1175 regions of differential CG dinucleotide methylation between at least one ES or iPS cell line. By comparing these regions of differential methylation with regions of cytosine methylation in the original somatic cells, 44-49% of differentially methylated regions reflected methylation patterns of the respective progenitor somatic cells, while 51-56% of these regions were dissimilar to both the progenitor and embryonic cell lines. [[In vitro]]-induced differentiation of iPSC lines saw transmission of 88% and 46% of hyper and hypo-methylated differentially methylated regions, respectively. Two conclusions are readily apparent from this study. First, epigenetic processes are heavily involved in [[cell fate determination]], as seen from the similar levels of cytosine methylation between induced pluripotent and embryonic stem cells, consistent with their respective patterns of [[Transcription (genetics)|transcription]]. Second, the mechanisms of reprogramming (and by extension, differentiation) are very complex and cannot be easily duplicated, as seen by the significant number of differentially methylated regions between ES and iPS cell lines. Now that these two points have been established, we can examine some of the epigenetic mechanisms that are thought to regulate cellular differentiation.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)